Table 3.

Longitudinal models on varenicline adherence and smoking abstinence

	Adherence			Abstinence
	OR	p-value	95 % CI	OR	p-value	95 % CI
Treatment
SC+TMa	0.87	.83	0.24, 3.09	0.62	.64	0.08, 4.54
SC+TM+ABTb	0.70	.59	0.20, 2.53	5.51	.05	0.99, 30.58
Timec	0.09	<.001	0.03, .25	1.53	.62	0.28, 8.37
Time*Treatment
SC+TM	0.81	.78	0.19, 3.51	0.17	.14	0.02, 1.84
SC+TM+ABT	0.41	.26	0.09, 1.93	8.84	.07	0.84, 92.40
Adherence to varenicline at the same visit				2.01	.13	0.82, 4.90
Baseline heaviness of smoking Index				0.61	.09	0.35, 1.07
Baseline adherence self-efficacyd	2.20	<.001	1.43, 3.39
Independent housing	1.02	.97	0.34, 3.08	6.13	.07	0.84, 44.96

Individuals’ intercepts vary with a standard deviation of 2.04 (95 % Cl 1.59–2.63) in the adherence model and 2.13 (95 % Cl 1.43–3.18) in the abstinence model

Bold values are statistically significant (p < 0.05)

^aThe SC+TM treatment condition is compared with SC

^bThe SC+TM+ABT treatment condition is compared with SC

^cTime variable is coded to contrast weeks 1 and 12

^dStandardized scores were used for baseline heaviness of smoking index and adherence self-efficacy